BazEkon - Biblioteka Główna Uniwersytetu Ekonomicznego w Krakowie

BazEkon home page

Meny główne

Wilde Sandra (Hamburg University of Applied Sciences), Wirth Tanja (Hamburg University of Applied Sciences), Zöllner York Francis (Hamburg University of Applied Sciences)
Mammography Screening in The OECD and Its Impact on Health and Health System Related Indicators
Journal of Health Policy and Outcomes Research, 2014, nr 1, s. 76-83, rys., tab., bibliogr. 25 poz.
Słowa kluczowe
Opieka zdrowotna, Zdrowie, Wskaźniki efektywności
Health care, Health, Effectiveness ratios
Mammography screening, with its primary aim of breast cancer mortality reduction, is well implemented in most OECD member states. Overdiagnosis and overtreatment are often controversially discussed as potential consequences of screening. The objective of this study was to examine whether high mammography screening rates are associated with (a) higher incidence of and (b) lower mortality rates from breast cancer, and (c) higher inpatient mastectomy rates in OECD countries. For this investigation, an ecological study design was chosen. Data of mammography screening rates, standardized incidence and mortality rates of breast cancer and inpatient mastectomy rates were derived from the database OECD.Stat Extracts for 2008 (or nearest year). Bar charts and scatter plots with associated R² were produced. Mammography screening rates showed a broad distribution among OECD states. Specific health indicators were, on average, less favorable in those countries where more women were screened. A high degree of variance explained by screening rates could be found for incidence rates of breast cancer and mastectomy rates (R²=0.522 and R²=0.258, respectively). For mortality rates, this was lower, but of medium size (R²=0.227)(original abstract)
Pełny tekst
  1. Bray F, Ren J-S, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132(5):1133-45
  2. Ferlay J, Parkin D, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. Elsevier Ltd; 2010;46(4):765-81
  3. Karsa L von, Anttila A, Ronco G, Ponti A, Malila N, Arbyn M, et al. Cancer screening in the European Union. Report on the implementation of the Council Recommendation on cancer screening. Luxembourg: European Communities; 2008
  4. Jørgensen K. Mammography screening. Benefits, harms, and informed choice. Dan Med J. 2013;60(4):1-26
  5. OECD. Health at a Glance 2011: OECD Indicators. OECD Publishing; 2011
  6. Puliti D, Zappa M. Breast cancer screening: are we seeing the benefit? BMC Med. 2012;10:106
  7. Gøtzsche P, Nielsen M. Screening for breast cancer with mammography (Review). Cochrane Libr. 2009;(4):1-70
  8. Miller A, Wall C, Baines C, Sun P, To T, Narod SA. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ. 2014;348(g366):1-10
  9. Jørgensen KJ, Zahl P-H, Gøtzsche PC. Overdiagnosis in organised mammography screening in Denmark. A comparative study. BMC Womens Health. 2009;9:36
  10. Njor S, Nyström L, Moss S, Paci E, Broeders M, Segnan N, et al. Breast cancer mortality in mammographic screening in Europe: a review of incidence-based mortality studies. J Med Screen. 2012;19 Suppl 1:33-41
  11. OECD Health Data 2012 Definitions , Sources and Methods Cancer [Internet]. 2012 [cited 2014 Apr 8]. Available from: VAR . CANCBREC &ShowOnWeb=true&Lang=en
  12. OECD Health Data 2012 Definitions , Sources and Methods - Causes of mortality [Internet]. 2012 [cited 2014 Apr 8]. Available from: VAR . CICDMNBR &ShowOnWeb=true&Lang=en
  13. OECD Health Data 2012 Definitions , Sources and Methods - Surgical procedures by ICD-9-CM [Internet]. 2012 [cited 2014 Apr 8]. Available from: VAR . VARPMAST &ShowOnWeb=true&Lang=en
  14. Field A. Correlation. In: Field A, editor. Discovering Statistics Using SPSS. 4th Editio. London: Sage Publications; 2013. p. 262-90.
  15. Gordis L. Epidemiology. Clemens S, Schäfer T, Groos J, editors. Marburg: KILIAN Verlag; 2001
  16. Mathers CD, Fat DM, Inoue M, Rao C, Lopez AD. Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull World Health Organ. 2005;83(3):171-7
  17. Stang A, Kääb-Sanyal V, Hense H-W, Becker N, Kuss O. Effect of mammography screening on surgical treatment for breast cancer: a nationwide analysis of hospitalization rates in Germany 2005-2009. Eur J Epidemiol. 2013;28(8):689-696
  18. Biller-Andorno N, Jüni P. Abolishing mammography screening programs? A view from the Swiss Medical Board. N Engl J Med. 2014;370(21):1965-7
  19. Marmot M. The benefits and harms of breast cancer screening: an independent review. Lancet. Elsevier Ltd; 2012;380(9855):1778-86
  20. Pace LE, Keating NL. A systematic assessment of benefits and risks to guide breast cancer screening decisions. JAMA. 2014;311(13):1327-35
  21. Broeders M, Moss S, Nyström L, Njor S, Jonsson H, Paap E, et al. The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies. J Med Screen. 2012;19 Suppl 1:14-25
  22. Son BH, Kwak BS, Kim JK, Kim HJ, Hong SJ, Lee JS, et al. Changing patterns in the clinical characteristics of Korean patients with breast cancer during the last 15 years. Arch Surg. 2006;141(2):155-60
  23. Allemani C, Storm H, Voogd AC, Holli K, Izarzugaza I, Torrella-Ramos A, et al. Variation in "standard care" for breast cancer across Europe: a EUROCARE-3 high resolution study. Eur J Cancer. 2010;46(9):1528-36
  24. Suhrke P, Mæhlen J, Schlichting E. Effect of mammography screening on surgical treatment for breast cancer in Norway : comparative. BMJ. 2011;343:1-8
  25. Deutsches Ärzteblatt. "Die Sensitivität des Mammopgraphie-Screeningprogramms ist gut" [Internet]. 2014 [cited 2014 Jul 25]. Available from:
Cytowane przez
Udostępnij na Facebooku Udostępnij na Twitterze Udostępnij na Google+ Udostępnij na Pinterest Udostępnij na LinkedIn Wyślij znajomemu